Beth Safirstein

Statistics

Publications

Citations

4.5K

H-Index

Active since

1999

Affiliations

University of North Carolina at Chapel Hill(Current)

Fred Hutch Cancer Center

Novavax (United States)

National Institute of Allergy and Infectious Diseases

Brigham and Women's Hospital

Beth Safirstein is an author at University of North Carolina at Chapel Hill specializing in dementia, neurodegenerative diseases, and alzheimer disease.

Publications per year

1999–2025

Publications

Donanemab in Early Symptomatic Alzheimer Disease

John R. Sims, Jennifer A. Zimmer, Cynthia Evans et al. · JAMA · 2023 · 2.6K citations · Full text

Medicine, Neurology, Neuroscience +17

Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico

Lisa M. Dunkle, Karen L. Kotloff, Cynthia L. Gay et al. · New England Journal of Medicine · 2021 · 453 citations · Full text

Veterinary Medicine, Infectious Diseases, Preventive Medicine +17

Safety and Tolerability of Multiple Ascending Doses of PRX002/RG7935, an Anti–α-Synuclein Monoclonal Antibody, in Patients With Parkinson Disease

Joseph Jankovic, Ira Goodman, Beth Safirstein et al. · JAMA Neurology · 2018 · 292 citations · Full text

Life Sciences, Neurology, Pharmacotherapy +17

Amyloid-β assessed by florbetapir F 18 PET and 18-month cognitive decline

P. Murali Doraiswamy, Reisa A. Sperling, Robert E. Coleman et al. · Neurology · 2012 · 228 citations · Full text

Medicine, Neurology, Nuclear Medicine +17

Subregional neuroanatomical change as a biomarker for Alzheimer's disease

Dominic Holland, James Brewer, Donald J. Hagler et al. · Proceedings of the National Academy of Sciences · 2009 · 213 citations · Full text

Life Sciences, Neurology, Neuroscience +17

1–5 of 17